Literature DB >> 27187164

Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer.

Francesca V Mertan1, Matthew D Greer, Sam Borofsky, Ismail M Kabakus, Maria J Merino, Bradford J Wood, Peter A Pinto, Peter L Choyke, Baris Turkbey.   

Abstract

There is growing consensus that multiparametric magnetic resonance imaging (mpMRI) is an effective modality in the detection of locally recurrent prostate cancer after prostatectomy and radiation therapy. The emergence of magnetic resonance (MR)-guided focal therapies, such as cryoablation, high-intensity focused ultrasound, and laser ablation, have made the use of mpMRI even more important, as the normal anatomy is inevitably altered and the detection of recurrence is made more difficult. The aim of this article is to review the utility of mpMRI in detecting recurrent prostate cancer in patients following radical prostatectomy, radiation therapy, and focal therapy and to discuss expected post-treatment mpMRI findings, the varied appearance of recurrent tumors, and their mimics.

Entities:  

Mesh:

Year:  2016        PMID: 27187164      PMCID: PMC5462597          DOI: 10.1097/RMR.0000000000000088

Source DB:  PubMed          Journal:  Top Magn Reson Imaging        ISSN: 0899-3459


  92 in total

1.  Rate of PSA rise predicts metastatic versus local recurrence after definitive radiotherapy.

Authors:  C I Sartor; M H Strawderman; X H Lin; K E Kish; P W McLaughlin; H M Sandler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-07-15       Impact factor: 7.038

2.  Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis.

Authors:  Eric M Horwitz; Lawrence B Levy; Howard D Thames; Patrick A Kupelian; Alvaro A Martinez; Jeffrey M Michalski; Thomas M Pisansky; Howard M Sandler; William U Shipley; Michael J Zelefsky; Anthony L Zietman; Deborah A Kuban
Journal:  Cancer       Date:  2006-10-01       Impact factor: 6.860

3.  Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging.

Authors:  Stefano Cirillo; Massimo Petracchini; Lorenza Scotti; Teresa Gallo; Annalisa Macera; Maria Cristina Bona; Cinzia Ortega; Pietro Gabriele; Daniele Regge
Journal:  Eur Radiol       Date:  2008-09-30       Impact factor: 5.315

4.  MRI findings of radiation-induced changes in the urethra and periurethral tissues after treatment for prostate cancer.

Authors:  Chiara Marigliano; Olivio F Donati; Hebert Alberto Vargas; Oguz Akin; Debra A Goldman; James A Eastham; Michael J Zelefsky; Hedvig Hricak
Journal:  Eur J Radiol       Date:  2013-09-22       Impact factor: 3.528

5.  Incremental value of diffusion weighted and dynamic contrast enhanced MRI in the detection of locally recurrent prostate cancer after radiation treatment: preliminary results.

Authors:  Oguz Akin; David H Gultekin; Hebert Alberto Vargas; Junting Zheng; Chaya Moskowitz; Xin Pei; Dahlia Sperling; Lawrence H Schwartz; Hedvig Hricak; Michael J Zelefsky
Journal:  Eur Radiol       Date:  2011-05-01       Impact factor: 5.315

6.  Prostate-specific antigen (PSA) bounce and other fluctuations: which biochemical relapse definition is least prone to PSA false calls? An analysis of 2030 men treated for prostate cancer with external beam or brachytherapy with or without adjuvant androgen deprivation therapy.

Authors:  Tom Pickles
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-01-10       Impact factor: 7.038

7.  The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome.

Authors:  A L Zietman; J J Coen; K C Dallow; W U Shipley
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-05-15       Impact factor: 7.038

8.  Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.

Authors:  Catherine Roy; Fatah Foudi; Jeanne Charton; Michel Jung; Hervé Lang; Christian Saussine; Didier Jacqmin
Journal:  AJR Am J Roentgenol       Date:  2013-04       Impact factor: 3.959

9.  T2-Weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy.

Authors:  Antonio C Westphalen; John Kurhanewicz; Rui M G Cunha; I-Chow Hsu; John Kornak; Shoujun Zhao; Fergus V Coakley
Journal:  Int Braz J Urol       Date:  2009 Mar-Apr       Impact factor: 1.541

Review 10.  Functional and molecular imaging of localized and recurrent prostate cancer.

Authors:  Kinzya Grant; Maria L Lindenberg; Haytham Shebel; Yuxi Pang; Harsh K Agarwal; Marcelino Bernardo; Karen A Kurdziel; Baris Turkbey; Peter L Choyke
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-07       Impact factor: 9.236

View more
  13 in total

Review 1.  Prostate MR Imaging for Posttreatment Evaluation and Recurrence.

Authors:  Sonia Gaur; Baris Turkbey
Journal:  Radiol Clin North Am       Date:  2017-11-27       Impact factor: 2.303

Review 2.  PET imaging of recurrent and metastatic prostate cancer with novel tracers.

Authors:  Francesca V Mertan; Liza Lindenberg; Peter L Choyke; Baris Turkbey
Journal:  Future Oncol       Date:  2016-08-16       Impact factor: 3.404

3.  Prospective comparison of whole-body MRI and 68Ga-PSMA PET/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy.

Authors:  Lino M Sawicki; Julian Kirchner; Carolin Buddensieck; Christina Antke; Tim Ullrich; Lars Schimmöller; Johannes Boos; Christoph Schleich; Benedikt M Schaarschmidt; Christian Buchbender; Philipp Heusch; Robert Rabenalt; Peter Albers; Gerald Antoch; Hans-Wilhelm Müller; Hubertus Hautzel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-03-16       Impact factor: 9.236

Review 4.  Therapeutic Ultrasound and Prostate Cancer.

Authors:  Karthik M Sundaram; Sam S Chang; David F Penson; Sandeep Arora
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

5.  Accuracy of 68Ga-PSMA-11 PET/CT and multiparametric MRI for the detection of local tumor and lymph node metastases in early biochemical recurrence of prostate cancer.

Authors:  Maija Radzina; Mara Tirane; Lilita Roznere; Liene Zemniece; Laura Dronka; Marika Kalnina; Edgars Mamis; Juergen Biederer; Vilnis Lietuvietis; Arvis Freimanis; Egils Vjaters
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-04-15

6.  Detection and staging of radio-recurrent prostate cancer using multiparametric MRI.

Authors:  Jie-Ying Kowa; Neil Soneji; S Aslam Sohaib; Erik Mayer; Stephen Hazell; Nicholas Butterfield; Joshua Shur; Derfel Ap Dafydd
Journal:  Br J Radiol       Date:  2021-02-15       Impact factor: 3.039

7.  Clinical outcomes associated with prostate cancer conspicuity on biparametric and multiparametric MRI: a protocol for a systematic review and meta-analysis of biochemical recurrence following radical prostatectomy.

Authors:  Naomi Morka; Benjamin S Simpson; Rhys Ball; Alex Freeman; Alex Kirkham; Daniel Kelly; Hayley C Whitaker; Mark Emberton; Joseph M Norris
Journal:  BMJ Open       Date:  2021-05-05       Impact factor: 2.692

Review 8.  Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?

Authors:  Fabio Zattoni; Isabel Heidegger; Veeru Kasivisvanathan; Alexander Kretschmer; Giancarlo Marra; Alessandro Magli; Felix Preisser; Derya Tilki; Igor Tsaur; Massimo Valerio; Roderick van den Bergh; Claudia Kesch; Francesco Ceci; Christian Fankhauser; Giorgio Gandaglia
Journal:  Front Surg       Date:  2021-07-09

Review 9.  Positron emission tomography (PET) in primary prostate cancer staging and risk assessment.

Authors:  Sandra Bednarova; Maria L Lindenberg; Maria Vinsensia; Chiara Zuiani; Peter L Choyke; Baris Turkbey
Journal:  Transl Androl Urol       Date:  2017-06

Review 10.  Percutaneous MR-guided prostate cancer cryoablation technical updates and literature review.

Authors:  Pierre de Marini; Roberto Luigi Cazzato; Julien Garnon; Behnam Shaygi; Guillaume Koch; Pierre Auloge; Thibault Tricard; Hervé Lang; Afshin Gangi
Journal:  BJR Open       Date:  2019-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.